Lyell Immunopharma (LYEL) Earnings Date, Estimates & Call Transcripts → Write this ticker symbol down… (From StocksToTrade) (Ad) Free LYEL Stock Alerts $2.43 -0.05 (-2.02%) (As of 06/7/2024 08:52 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateAug. 13EstimatedActual EPS (May. 6) -$0.24 Missed By -$0.04 Consensus EPS (May. 6) -$0.20 Get Lyell Immunopharma Earnings AlertsEnter your email address below to receive the latest news and earnings results for LYEL and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueLYEL Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.LYEL Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Smallcaps DailyIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promising companies to be watching closelyLearn how this American company is leading the lithium-ion revolution Lyell Immunopharma Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($0.85) EPSNext Year EPS Consensus Estimate: ($0.85) EPSLYEL Earnings Date and InformationLyell Immunopharma last issued its quarterly earnings results on May 6th, 2024. The reported ($0.24) EPS for the quarter, missing analysts' consensus estimates of ($0.20) by $0.04. Lyell Immunopharma has generated ($0.90) earnings per share over the last year (($0.90) diluted earnings per share). Earnings for Lyell Immunopharma are expected to remain at ($0.85) per share in the coming year. Lyell Immunopharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off prior year's report dates.Read More Lyell Immunopharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/13/2024(Estimated)------- 5/6/2024Q1 2024($0.20)($0.24)($0.04)($0.24)--2/28/2024Q4 2023($0.21)($0.20)+$0.01($0.20)$4.96 million$0.01 million11/7/2023Q3 2023($0.27)($0.20)+$0.07($0.20)$2.50 million$0.03 million8/8/2023Q2 2023($0.30)($0.26)+$0.04($0.26)$3.31 million$0.03 million5/4/2023Q1 2023($0.28)($0.27)+$0.01($0.27)$2.50 million$0.07 million2/28/2023Q4 2022($0.31)($0.03)+$0.28($0.03)$2.85 million$48.39 million Get the Latest News and Ratings for LYEL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lyell Immunopharma and its competitors with MarketBeat's FREE daily newsletter. 11/8/2022Q3 2022($0.34)($0.28)+$0.06($0.28)--8/4/2022Q2 2022($0.31)($0.15)+$0.16($0.15)$3.37 million$35.74 million5/10/2022Q1 2022($0.27)($0.28)($0.01)($0.28)$2.66 million$0.55 million3/29/2022Q4 2021-($0.18)($0.18)($0.18)$2.64 million$2.82 million11/12/2021Q3 2021($0.27)($0.20)+$0.07($0.20)$2.42 million$2.76 million8/12/2021Q2 2021($1.54)($1.25)+$0.29($1.03)$2.42 million$2.63 million Lyell Immunopharma Earnings - Frequently Asked Questions When is Lyell Immunopharma's earnings date? Lyell Immunopharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off last year's report dates. Learn more on LYEL's earnings history. Did Lyell Immunopharma beat their earnings estimates last quarter? In the previous quarter, Lyell Immunopharma (NASDAQ:LYEL) missed the analysts' consensus estimate of ($0.20) by $0.04 with a reported earnings per share (EPS) of ($0.24). Learn more on analysts' earnings estimate vs. LYEL's actual earnings. How much revenue does Lyell Immunopharma generate each year? Lyell Immunopharma (NASDAQ:LYEL) has a recorded annual revenue of $68,000.00. How much profit does Lyell Immunopharma generate each year? Lyell Immunopharma (NASDAQ:LYEL) has a recorded net income of -$234.63 million. LYEL has generated -$0.90 earnings per share over the last four quarters. What is Lyell Immunopharma's EPS forecast for next year? Lyell Immunopharma's earnings are expected to stay at ($0.85) per share in the next year. More Earnings Resources from MarketBeat Related Companies: ALEC Earnings Results VERV Earnings Results ERAS Earnings Results BCYC Earnings Results ALLO Earnings Results ADCT Earnings Results BLUE Earnings Results ACHL Earnings Results IOVA Earnings Results PTCT Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: CrowdStrike's Earnings: Consolidation and AI-Driven Growth The Most Upgraded Stocks After the Q1 Earnings Season ZIM Shipping Stock Forecast, Earnings Triggers a BuyAmerican Superconductor's Earnings Surge, Future Growth ExpectedHormel: A Potential Buy Despite Post-Earnings DeclineCanopy Growth’s Earnings: Profitability Despite Industry ShiftsAbercrombie & Fitch First Quarter Earnings Surge to New Heights This page (NASDAQ:LYEL) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredYou won't believe what Citigroup just did to it's depositorsThe FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st...American Alternative | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lyell Immunopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lyell Immunopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.